Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results

Last Modified: 4/29/2008 First Published: 2/21/2003


1.		Phase III Randomized Study of Ultraviolet A Light Therapy With Methoxsalen (PUVA) With or Without Bexarotene in Patients With Mycosis Fungoides

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Over 18				Other				EORTC-21011 NCT00056056

Last Modified: 6/22/2007 First Published: 11/10/2005


2.		Phase II Study of Doxorubicin HCl Liposome Followed By Bexarotene in Patients With Stage IB-IV Cutaneous T-Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				MSKCC-05098 NCT00255801

Last Modified: 5/22/2008 First Published: 1/16/2007


3.		Phase II Study of Bexarotene and Sargramostim (GM-CSF) in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				JHOC-J0675 JHOC-NA_00003076, NCT00425477


4.		BATTLE Program: Tarceva and Targretin in Patients With NSCLC

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				2005-0826 NCT00411632

Last Modified: 10/7/2008 First Published: 8/3/2007


5.		Phase II Study of Bexarotene and Tretinoin With Combination Chemotherapy Comprising Cisplatin or Carboplatin, Docetaxel, and Capecitabine in Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Pharmaceutical / Industry				EISAI-2007-01-22 2007-01-22, NCT00514293


6.		Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				UPCC 04407 UPCC 04407, NCT00615784

First Published: 4/15/2008


7.		Phase II Study of Gemcitabine Hydrochloride and Bexarotene in Patients With Progressive or Refractory Stage IB-IVA Cutaneous T-cell Non-Hodgkin Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				CRUK-UCL-GEMBEX CRUK-UCL GemBex, EU-20841, EUDRACT 2006-000591-33, NCT00660231


8.		Study of Tarceva and Targretin in Stage I-II Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				18 and over				Other				D-0453 NCT00125372


9.		A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoind and Peroxisome-Proliferator-Activated Receptor (PPARy) Expression

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				18 and over				Other				COMIRB# 07-0727 NCT00718770

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute